Intraductal oncocytic papillary neoplasms of the pancreas and bile ducts: a description of five new cases and review based on a systematic survey of the literature

Łukasz Liszka1, Jacek Pająk1, Ewa Zielińska-Pająk1, Łukasz J. Krzych2, Dariusz Gołka3, Sławomir Mrowiec4, Paweł Lampe4
1Department of Histopathology Medical University of Silesia ul. Medyków 18 40‐754 Katowice Poland
2Department of Epidemiology Medical University of Silesia ul. Medyków 18 40‐754 Katowice Poland
3Department of Pathology, Victoria Hospital, Whinney Heys Road, Blackpool, FY3 8NR UK
4Department of Gastrointestinal Surgery Medical University of Silesia ul. Medyków 18 Katowice 40‐754 Poland

Tóm tắt

AbstractBackground

Intraductal oncocytic papillary neoplasms (IOPN) are rare tumors of the pancreatic and biliary ductal system. It is not absolutely clear if the molecular and clinicopathologic characteristics of IOPN differ significantly from other related lesions, namely intraductal papillary mucinous neoplasms (IPMN). Therefore it is not clear if it is reasonable to consider IOPN as a separate diagnostic and clinical entity.

Methods

In order to describe the clinicopathologic characteristics of IOPN and to compare them with the IPMN profile, we performed a systematic review of the literature and additionally studied five previously unreported IOPN cases.

Results

IOPN differ from IPMN by lack of K‐ras gene mutations in all studied cases. Several differences in the clinical and biological profile between IOPN and IPMN exist, but they are of quantitative rather than of qualitative nature. Additionally, pancreaticobiliary or gastric‐foveolar IPMN components may coexist with IOPN component within a single lesion, which suggests at least a partial relation of the pathogenetic pathways of IPMN and IOPN. Importantly, the pathogenesis of accumulation of mitochondria and oxyphilic appearance of IOPN remains unknown.

Conclusions

At present, there are no reliable criteria other than histopathological picture and K‐ras gene status to differentiate IOPN from IPMN. In particular, no clear differences in optimal treatment options and prognosis between these tumors are known. Further studies are needed to clarify the biology of IOPN and to establish their position in clinicopathologic classifications of pancreatic tumors.

Từ khóa


Tài liệu tham khảo

Hruban RH, 2007, AFIP atlas of tumor pathology. Fourth series. Fascicle 6. Tumors of the pancreas

Adsay NV, 2000, Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms, Semin Diagn Pathol., 17, 16

10.1007/s00428-005-0039-7

10.1097/01.pas.0000126675.59108.80

10.1097/01.pas.0000213305.98187.d4

10.1097/mpa.0b013e31806da090

10.1097/00000478-200407000-00001

10.1097/00000478-200107000-00014

10.1097/MPA.0b013e31802dea0

10.1053/jhep.2001.28199

10.1038/modpathol.3800643

10.1007/s00428-008-0682-x

10.1038/modpathol.3880479

10.1002/hep.21387

10.1007/s00534-009-0070-1

10.1007/s00428-009-0767-1

10.1097/00000478-199608000-00007

10.1016/j.humpath.2009.03.014

Basturk O, 2009, Pancreatic cysts. Pathologic classification, differential diagnosis and clinical implications, Arch Pathol Lab Med., 133, 423, 10.5858/133.3.423

10.1016/S1665-2681(19)31876-9

Chung SM, 2005, Analysis of molecular alterations and differentiation pathways in intraductal oncocytic papillary neoplasms of the pancreas, Mod Pathol., 18, 277A

Ban S, 2006, Intraductal papillary neoplasms of the pancreas with intraluminal growth showing arborizing papillae: a subset of neoplasms combining intraductal oncocytic papillary neoplasms (IOPNs) and intraductal papillary mucinous neoplasms (IPMNs) of the gastric type, Mod Pathol., 19, 268A

Khayyata S, 2006, MUC6 expression distinguishes intraductal oncocytic and pancreatobiliary type from intestinal type papillae in pancreatic neoplasia: delineation of a pyloropancreatic pathway, Mod Pathol., 19, 275A

Chen ZM, 2008, Mist1 expression in acinar carcinomas and intraductal oncocytic papillary neoplasm of the pancreas, Mod Pathol., 21, 302A

Furukawa T, 2008, Characteristic clinicopathological phenotypes of the types of intraductal papillary‐mucinous neoplasm of the pancreas: a Japanese multi‐institutional study, Mod Pathol., 21, 304A

Hsu M, 2008, Molecular alterations in morphologic subtypes of pancreatic intraductal papillary mucinous neoplasm (IPMN) are distinct from those seen in pancreatic ductal adenocarcinoma, Mod Pathol., 21, 305A

Hsu M, 2008, Expression of inflammatory mediators in pancreatic intraductal papillary mucinous neoplasm (IPMN), Mod Pathol., 21, 305A

10.1007/s00428-007-0512-6

10.1002/1097-0142(19890915)64:6<1329::AID-CNCR2820640627>3.0.CO;2-S

10.1111/j.1572-0241.1998.00714.x

10.1002/(SICI)1097-0339(199804)18:4<291::AID-DC9>3.0.CO;2-F

10.1016/S0016-5107(99)70180-X

10.1097/00000478-200208000-00014

10.1385/IJGC:32:1:43

10.1007/s00595-004-2864-8

Oku T, 2007, Intraductal oncocytic papillary neoplasm having clinical characteristics of mucinous cystic neoplasm and a benign histology, JOP J Pancreas (Online), 8, 206

Kato Y, 2008, Intraductal oncocytic papillary neoplasm of the pancreas with strong accumulation on FDG‐PET, HepatoGastroenterology, 55, 900

Sanada Y, 2008, Comparison of histologic subtype and growth pattern in intraductal papillary‐mucinous carcinoma of the pancreas, Oncol Rep., 19, 1435

Wolf HK, 1992, Oncocytic differentiation in intrahepatic biliary cystadenocarcinoma, Mod Pathol., 5, 665

10.1002/cncr.10934

10.1111/j.1440-1827.2004.01594.x

Spector SA, 2004, Intraductal oncocytic papillary neoplasm of the extrahepatic biliary tree: first report, Am Surg., 70, 55, 10.1177/000313480407000113

Bardin RL, 2004, Oncocytic biliary cystadenocarcinoma. A case report and review of the literature, Arch Pathol Lab Med., 128, e25, 10.5858/2004-128-e25-OBCACR

10.1111/j.1365-2559.2006.02441.x

10.1080/00313020701444531

Itatsu K, 2007, Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma, HepatoGastroenterology, 54, 677

10.1016/j.anndiagpath.2006.09.003

10.1186/1757-1626-1-319

10.1016/j.crad.2009.02.017

10.1097/01.sla.0000114132.47816.dd

10.1016/j.anndiagpath.2004.12.002

10.1016/j.humpath.2005.11.002

10.1111/j.1440-1827.2007.02143.x

10.1038/modpathol.3800763

10.1038/modpathol.2008.77

10.1097/00000478-200403000-00005

10.1016/j.jhep.2005.09.025

10.1016/j.humpath.2007.11.018

Ji Y, 2008, Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas, Histol Histopathol., 23, 41

Nappi O, 1999, Neoplasms composed of eosinophilic polygonal cells: an overview with consideration of different cytomorphologic patterns, Semin Diagn Pathol., 16, 82

10.1002/1097-0142(196209/10)15:5<1019::AID-CNCR2820150519>3.0.CO;2-5

10.1007/s004280050209

10.1002/1097-0142(19830115)51:2<332::AID-CNCR2820510228>3.0.CO;2-N

10.1016/j.humpath.2008.10.005

10.1007/s00428-009-0766-2

Longnecker DS, 2001, Pathology and genetics of tumours of the digestive system, 237

Albores‐Saavedra J, 2000, Atlas of tumor pathology. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater

10.1111/j.1440-1827.2006.02042.x

Papotti M, 1999, Oncocytic and oncocytoid tumors of the exocrine pancreas, liver, and gastrointestinal tract, Semin Diagn Pathol., 16, 126

10.1097/00006676-199301000-00023

10.1111/j.1440-1827.2008.02336.x

10.1097/00000478-200402000-00011

10.1097/01.pas.0000157939.03409.ec

10.1111/j.1440-1827.2007.02163.x

10.1002/path.1711460103

10.1097/MPA.0b013e318162a10f

SimonsJP NgSC ShahSA McDadeTP WhalenGF TsengJF.Malignant intraductal papillary mucinous neoplasm: are we doing the right thing?J Surg Res.2010(in press).

10.1097/SLA.0b013e31815c2a29

Belyaev O, 2008, Intraductal papillary mucinous neoplasms of the pancreas, J Clin Gastroenterol., 42, 284, 10.1097/MCG.0b013e3180500761

10.1038/modpathol.3800706

10.1080/00313020802436444

Kanehira K, 2008, High endogenous avidin binding activity: an inexpensive and readily available marker for the differential diagnosis of kidney neoplasms, Int J Clin Exp Pathol., 1, 435

10.1002/(SICI)1096-9896(1998110)186:3<292::AID-PATH190>3.0.CO;2-Y

10.1007/s004280000219

10.1007/s00534-009-0105-7

10.1016/S0046-8177(03)00337-X

10.1309/F1B64CL7H8VJKEAF

10.1097/01.MP.0000072748.65178.2F

10.1016/S0002-9440(10)64589-0

10.1136/gut.50.6.861

10.1097/01.pas.0000213370.79300.e1

Safo AF, 2007, HepPar1 expression in intraductal papillary mucinous neoplasms (IPMN) and mucinous cystic neoplasms (MCN) of the pancreas with and without dysplasia and invasive carcinoma, Mod Pathol., 20, 291A

10.1159/000090023

10.1002/jso.20387

10.1245/ASO.2005.02.030

10.1097/01.sla.0000128306.90650.aa